T 0408/17 (Method for producing a soluble, antigen-specific VH binding domain/ERASMUS UNIVERSITY and CRAIG ROGER) of 26.01.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T040817.20220126
- Date of decision
- 26 January 2022
- Case number
- T 0408/17
- Petition for review of
- -
- Application number
- 05766644.8
- IPC class
- A01K 67/027C07K 16/00C12N 5/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Binding molecules
- Applicant name
- Erasmus University Medical Center Rotterdam
Craig, Roger Kingdon - Opponent name
- Regeneron Pharmaceuticals, Inc.
Ablynx N.V.
Crescendo Biologics Limited (opposition withdrawn) - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.